Skip to content

A Non-dispensing Fit Evaluation of Investigational Limbal Ring Soft Contact Lenses With Polyvinylpyrrolidone (PVP) in Asian Eyes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02036320
Enrollment
190
Registered
2014-01-15
Start date
2014-01-31
Completion date
2014-02-28
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vision Correction

Brief summary

The purpose of this clinical trial is to compare the overall lens fit acceptance of two different soft contact lenses in an Asian population.

Interventions

DEVICEetafilcon A

Each study subject will be exposed to both test lenses following a washout period of five minutes between test periods.

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 41 Years
Healthy volunteers
Yes

Inclusion criteria

1. The subject must read, understand, and sign the statement of informed consent and receive a fully executed copy of the form. 2. The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol. 3. The subject must be an Asian female (self-reported). 4. The subject must be at least 18 years old and less than 41 years old. 5. The subject must meet two of the four East Asian anatomical categories (Appendix D) and have a prominent epicanthic fold to be classified East Asian ethnicity. For the purpose of this protocol, East Asian ethnicities may include: China, Japan, Korea, Taiwan, Vietnam, Hong Kong, Malaysia, and Singapore but are not inclusive of these regions. 6. The subject must be a habitual soft contact lens wearer. Habitual is defined as: at least one month of daily wear where the lenses are worn a minimum of six (6) hours per day and a minimum of three (3) days per week prior to enrollment in the study. 7. The subject's optimal non-vertexed spherical equivalent distance correction (based on their optimal sphero-cylinder refraction) must be between +2.00 D and -12.00 D. 8. Any cylinder power must be less than or equal to -1.00 D confirmed by refraction. 9. The subject must possess a functional/usable pair of spectacles and wear them to the visit (only if applicable-to the investigator's discretion). 10. The subject's best correctable visual acuity is 20/40 or better (OD and OS) at the baseline visit.

Exclusion criteria

1. Ocular or systemic allergies which might interfere with contact lens wear. 2. Ocular or systemic disease which might interfere with contact lens wear. 3. Any known hypersensitivity or allergic reaction to contact lenses or contact lens solutions. 4. Use of any ocular or topical medication. 5. Use of any systemic (oral) medication that is taken for an ocular condition which might interfere with contact lens wear. 6. Use of any systemic (oral) medication that is taken for a systemic condition which might interfere with the contact lens wear (this determination will be at the discretion of the investigator). 7. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities, bulbar injection or any other abnormalities of the cornea and/or conjunctiva which would contraindicate contact lens wear. 8. Rigid gas permeable or hybrid design (rigid gas permeable center and a soft lens skirt) contact lens wear within the past 30 days. 9. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia. 10. Any previous or planned (during duration of the study), ocular or intraocular surgery (e.g. radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), peripheral iridotomy, etc.) 11. Pregnancy or lactation. 12. Diabetes. 13. Infectious disease. 14. Habitual contact lens type is multifocal, monovision or worn as extended wear. 15. Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment. 16. Suspicion of or recent history od alcohol or substance abuse. 17. History of serious mental illness. 18. History of seizures. 19. Employee or family member of the investigational clinic (e.g. Investigator, Coordinator, Technician).

Design outcomes

Primary

MeasureTime frameDescription
Mechanical Lens Fit Acceptance15 mins post insertionThe number of subject eyes that were classified as having acceptable mechanical lens fit, with a slit lamp.
Cosmetic Lens Fit Acceptance15 mins post insertionThe number of subject eyes that were classified as having acceptable cosmetic lens fit in primary gaze, without a slit lamp.
Lens Does Not Exhibit Hula Hoop Effect15 mins post insertionThe number of subjects that did not exhibit a hula hoop effect as recorded by Eye Care Practitioner (ECP) judgment of acceptable physiology, in primary gaze, without a slit lamp.

Countries

Canada, United States

Participant flow

Pre-assignment details

206 subjects were enrolled in this study. 16 subjects did not meet the eligibility criteria. 190 subjects were dispensed lenses and, 177 subjects completed all study visits without a major protocol deviation. 13 subjects were recorded as having protocol violations. No subjects were discontinued during this study.

Participants by arm

ArmCount
Overall
All subjects that were dispensed a test article during the study.
190
Total190

Baseline characteristics

CharacteristicOverall
Age, Continuous24.75 years
STANDARD_DEVIATION 4.416
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
190 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
Canada
29 participants
Region of Enrollment
United States
161 participants
Sex: Female, Male
Female
190 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 950 / 95
serious
Total, serious adverse events
0 / 950 / 95

Outcome results

Primary

Cosmetic Lens Fit Acceptance

The number of subject eyes that were classified as having acceptable cosmetic lens fit in primary gaze, without a slit lamp.

Time frame: 15 mins post insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation.

ArmMeasureValue (NUMBER)
Test 1Cosmetic Lens Fit Acceptance349 Eyes
Test 2Cosmetic Lens Fit Acceptance349 Eyes
Primary

Lens Does Not Exhibit Hula Hoop Effect

The number of subjects that did not exhibit a hula hoop effect as recorded by Eye Care Practitioner (ECP) judgment of acceptable physiology, in primary gaze, without a slit lamp.

Time frame: 15 mins post insertion

Population: The analysis population consists of subjects that completed all study visits, without a major protocol deviation

ArmMeasureValue (NUMBER)
Test 1Lens Does Not Exhibit Hula Hoop Effect176 Subject
Test 2Lens Does Not Exhibit Hula Hoop Effect176 Subject
Primary

Mechanical Lens Fit Acceptance

The number of subject eyes that were classified as having acceptable mechanical lens fit, with a slit lamp.

Time frame: 15 mins post insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation.

ArmMeasureValue (NUMBER)
Test 1Mechanical Lens Fit Acceptance345 Eyes
Test 2Mechanical Lens Fit Acceptance337 Eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026